Cypress Wealth Services’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-11,938
Closed -$720K 313
2020
Q3
$720K Buy
+11,938
New +$719K 0.18% 98

Other funds holding BMY

Cypress Wealth Services's BMY Position: Q4 2023 in Review

Cypress Wealth Services sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 4,742 shares — an estimated $275K sold.

Cypress Wealth Services first reported a position in BMY in Q4 2017 and held it in 23 quarters. The position peaked at $894K in Q1 2021. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

  • Cypress Wealth Services reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
  • Cypress Wealth Services sold 4,742 Bristol-Myers Squibb shares in Q4 2023, an estimated $275K.
  • Cypress Wealth Services first reported a position in Bristol-Myers Squibb in Q4 2017 and held it in 23 quarters.
  • Cypress Wealth Services's Bristol-Myers Squibb position peaked at $894K in Q1 2021.
  • 2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Cypress Wealth Services's 13F filing for Q4 2023, filed 11 Jan 2024.